Consun Pharmaceutical Group Ltd. | Cash Flow
Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
265,543.70
332,451.90
388,277.50
471,400.80
628,411.60
730,451.50
Depreciation, Depletion & Amortization
16,234.50
19,956.50
22,929.20
46,866.40
76,631.80
84,708.60
Other Funds
38,652.70
84,068.50
-
-
12,404.90
82,390.60
Funds from Operations
224,838.20
352,509.10
368,501.10
495,707.40
584,039.70
732,769.50
Changes in Working Capital
14,333.10
48,098.50
124,949.10
54,215.80
317,017.00
147,220.50
Net Operating Cash Flow
210,505.10
400,607.60
243,552.00
549,923.20
267,022.60
879,990
Capital Expenditures
80,857.20
26,393.90
21,315.80
76,447.30
63,384.00
Sale of Fixed Assets & Businesses
836.50
-
648.80
89,351.30
4,342.50
Purchase/Sale of Investments
96,483.60
315,765.10
481,602.70
36,936.00
-
Net Investing Cash Flow
16,462.90
342,158.90
579,310.40
2,673.30
69,969.30
Cash Dividends Paid - Total
229,515.40
47,824.10
34,537.50
133,797.90
199,750.40
Issuance/Reduction of Debt, Net
-
-
-
105,157.70
685,672.70
Net Financing Cash Flow
807,982.90
131,892.60
100,501.50
333,751.70
172,163.90
Net Change in Cash
1,034,950.80
73,444.00
436,259.90
213,498.10
365,360.20
Free Cash Flow
129,647.90
374,213.70
222,236.20
520,680.00
203,638.60
Net Assets from Acquisitions
-
-
-
21,358.70
-
Change in Capital Stock
1,076,151.00
-
65,964.10
94,796.10
301,353.50
Exchange Rate Effect
-
-
-
-
3,857.10
Other Uses
-
-
77,040.70
-
10,927.80
About Consun Pharmaceutical Group
View Profile
